Insider Monkey·2025-12-30 14:53Group 1: Market Outlook - Scott Wren, chief global equity strategist at Wells Fargo Investment Institute, expressed optimism about accelerating earnings and moderating inflation, projecting a 2.8% CPI target for the next year [1] - Wren characterized the combination of modest growth and moderating inflation as favorable for risk assets in the upcoming year [1] Group 2: Investment Strategy - The firm has utilized broad risk additions and internal sector rotations, shifting away from heavy concentrations in technology while maintaining a preference for US markets over international ones [2] - Wren indicated a neutral stance on developed international and emerging markets, favoring large-cap and mid-cap stocks [2] Group 3: Stock Performance and Analyst Ratings - Robinhood Markets Inc. (NASDAQ:HOOD) has a market capitalization of $105.52 billion and a year-to-date performance of 215.83% as of December 29, with 77 hedge fund holders [7] - Needham lowered its price target for Robinhood to $135 from $145, citing a prolonged slump in cryptocurrency trading volume [8] - Morgan Stanley raised its price target for Robinhood to $147 from $146, increasing Q4 EPS estimates by an average of 5% [9] - Barclays also increased its price target for Robinhood to $171 from $168, maintaining an Overweight rating [10] Group 4: Guardant Health Inc. Overview - Guardant Health Inc. (NASDAQ:GH) has a market capitalization of $13.18 billion and a year-to-date performance of 233.29% as of December 29, with 50 hedge fund holders [12] - Canaccord raised its price target for Guardant Health to $125 from $100, expecting the life science sector to maintain an upward trend into 2026 [12] - Mizuho and Bank of America also raised their price targets for Guardant Health to $120 from $100, maintaining positive ratings based on anticipated growth in the life sciences sector [13][14]